Alzheimer’s is a disease that impacts millions and heavily affects the brain and memory. Alzheimer’s impacts more than 6 million Americans, according to the Alzheimer's Association. It is mostly seen ...

Alzheimer’s disease is a progressive and debilitating condition that slowly robs a person of their memories and personality. Alzheimer’s disease is a form of dementia that produces various symptoms ...

"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

Alzheimer's is a disease that mostly affects older adults, and its most common symptom is a decline in memory. There are nearly 7 million Americans who live with Alzheimer's, according to the ...

Explore how smart pillboxes and dispensers help people with early-stage Alzheimer's manage medications effectively, ensuring ...

The damage caused by Alzheimer's disease begins long before any symptoms show up. Over the course of years or decades in this preclinical stage, the characteristic buildup of disease-causing amyloid ...

Today we begin a several-part series on Alzheimer’s disease, the most common cause of memory loss and dementia. Alzheimer’s is a brain disease characterized by amyloid plaques and neurofibrillary ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Standing on a purple Walk to End Alzheimer’s stage in front of a crowd holding purple, yellow and orange pinwheel flowers ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s disease despite improving bio ...